Metformin/Atorvastatin Combination Therapy in Subjects With Type II Diabetes and Dyslipidemia (Phase 3)

NCT02947620 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

185

Enrollment

INDUSTRY

Sponsor class

Conditions

Type II Diabetes
Dyslipidemia

Interventions

DRUG: Metformin/Atorvastatin 1500mg/40mg, QD
DRUG: Metformin 1500mg, QD
DRUG: Atorvastatin 40mg, QD

Sponsor

Daewoong Pharmaceutical Co. LTD.